Mohammad Reza Shadmand Foumani Moghadam, Mostafa Shahraki Jazinaki, Mina Rashidipour, Reza Rezvani, Parnian Pezeshki, Majid Ghayour Mobarhan, Zohre Hosseini
{"title":"Mini Nutrition Assessment-Short Form score与肌少症相关,即使在营养丰富的人群中也是如此-一项登记可行性研究的结果","authors":"Mohammad Reza Shadmand Foumani Moghadam, Mostafa Shahraki Jazinaki, Mina Rashidipour, Reza Rezvani, Parnian Pezeshki, Majid Ghayour Mobarhan, Zohre Hosseini","doi":"10.1002/agm2.12257","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>This study aims to identify a new barrier to the use of the Mini-Nutrition Assessment Short-Form (MNA-SF), which is a malnutrition assessment tool for the risk assessment of sarcopenia in a nourished population.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>The MNA-SF was completed, and individuals with a score of > 11 were considered nourished in this cross-sectional feasibility study of a registry. Sarcopenia was assessed in 766 healthy, nourished adults (33.4% men, 64.9 ± 7.1 years) based on the European Working Group on Sarcopenia in Older People 2 (EWGSOP2).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The MNA-SF scores for non-sarcopenia, pre-, confirmed, and severe sarcopenia were 13.59 ± 0.69, 13.73 ± 0.60, 12.64 ± 0.74, and 12.5 ± 0.71, respectively. The higher MNA-SF score association with pre-sarcopenia [odds ratio (OR): 1.41, 95% confidence interval (CI): 1.06–1.86, <i>P</i> = 0.02], confirmed sarcopenia (OR = 0.25, 95% CI: 0.13–0.49, <i>P</i> < 0.001), and severe sarcopenia (OR = 0.20, 95% CI: 0.09–0.46, <i>P</i> < 0.001) was as significant as in the MNA-SF categories. Individuals with a score = 13 (compared with 14), had a higher risk of confirmed sarcopenia (OR = 10.07, 95% CI: 1.92–52.71, <i>P</i> = 006) and severe sarcopenia (OR = 12.09, 95% CI: 1.24–117.50, <i>P</i> = 0.032). Individuals with a score of 12 had a higher risk of confirmed sarcopenia (OR = 30.94, 95% CI: 4.25–103.02, <i>P</i> < 0.001) and severe sarcopenia (OR = 35.90, 95% CI: 4.25–303.07, <i>P</i> = 0.001) compared with subjects with a score of 14. The models also showed that MNA-SF < 13 could predict sarcopenia.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>There was a significant association between MNA-SF and confirmed and severe sarcopenia in nourished people. Sarcopenia assessment in people with MNA-SF < 13 can be beneficial. Developing a tool to identify the risk of malnutrition and sarcopenia at the same time based on MNA-SF can be considered.</p>\n </section>\n </div>","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"6 3","pages":"264-271"},"PeriodicalIF":2.2000,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0b/17/AGM2-6-264.PMC10498828.pdf","citationCount":"1","resultStr":"{\"title\":\"Mini Nutrition Assessment-Short Form score is associated with sarcopenia even among nourished people – A result of a feasibility study of a registry\",\"authors\":\"Mohammad Reza Shadmand Foumani Moghadam, Mostafa Shahraki Jazinaki, Mina Rashidipour, Reza Rezvani, Parnian Pezeshki, Majid Ghayour Mobarhan, Zohre Hosseini\",\"doi\":\"10.1002/agm2.12257\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Objectives</h3>\\n \\n <p>This study aims to identify a new barrier to the use of the Mini-Nutrition Assessment Short-Form (MNA-SF), which is a malnutrition assessment tool for the risk assessment of sarcopenia in a nourished population.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>The MNA-SF was completed, and individuals with a score of > 11 were considered nourished in this cross-sectional feasibility study of a registry. Sarcopenia was assessed in 766 healthy, nourished adults (33.4% men, 64.9 ± 7.1 years) based on the European Working Group on Sarcopenia in Older People 2 (EWGSOP2).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>The MNA-SF scores for non-sarcopenia, pre-, confirmed, and severe sarcopenia were 13.59 ± 0.69, 13.73 ± 0.60, 12.64 ± 0.74, and 12.5 ± 0.71, respectively. The higher MNA-SF score association with pre-sarcopenia [odds ratio (OR): 1.41, 95% confidence interval (CI): 1.06–1.86, <i>P</i> = 0.02], confirmed sarcopenia (OR = 0.25, 95% CI: 0.13–0.49, <i>P</i> < 0.001), and severe sarcopenia (OR = 0.20, 95% CI: 0.09–0.46, <i>P</i> < 0.001) was as significant as in the MNA-SF categories. Individuals with a score = 13 (compared with 14), had a higher risk of confirmed sarcopenia (OR = 10.07, 95% CI: 1.92–52.71, <i>P</i> = 006) and severe sarcopenia (OR = 12.09, 95% CI: 1.24–117.50, <i>P</i> = 0.032). Individuals with a score of 12 had a higher risk of confirmed sarcopenia (OR = 30.94, 95% CI: 4.25–103.02, <i>P</i> < 0.001) and severe sarcopenia (OR = 35.90, 95% CI: 4.25–303.07, <i>P</i> = 0.001) compared with subjects with a score of 14. The models also showed that MNA-SF < 13 could predict sarcopenia.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>There was a significant association between MNA-SF and confirmed and severe sarcopenia in nourished people. Sarcopenia assessment in people with MNA-SF < 13 can be beneficial. Developing a tool to identify the risk of malnutrition and sarcopenia at the same time based on MNA-SF can be considered.</p>\\n </section>\\n </div>\",\"PeriodicalId\":32862,\"journal\":{\"name\":\"Aging Medicine\",\"volume\":\"6 3\",\"pages\":\"264-271\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2023-06-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0b/17/AGM2-6-264.PMC10498828.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Aging Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/agm2.12257\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aging Medicine","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/agm2.12257","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 1
摘要
摘要本研究旨在为营养人群中肌少症风险评估的营养不良评估工具MNA-SF (Mini-Nutrition Assessment short form)的应用寻找新的障碍。方法:完成MNA-SF,在登记的横断面可行性研究中,评分为> 11的个体被认为是营养不良的。根据欧洲老年人肌肉减少症工作组2 (EWGSOP2),对766名健康营养的成年人(33.4%男性,64.9±7.1岁)进行了肌肉减少症评估。结果非肌少症、预肌少症、确诊肌少症和严重肌少症的MNA-SF评分分别为13.59±0.69、13.73±0.60、12.64±0.74和12.5±0.71。较高的MNA-SF评分与前期肌肉减少症[比值比(OR): 1.41, 95%可信区间(CI): 1.06-1.86, P = 0.02]、确诊的肌肉减少症(OR = 0.25, 95% CI: 0.13-0.49, P < 0.001)和严重的肌肉减少症(OR = 0.20, 95% CI: 0.09-0.46, P < 0.001)的相关性与MNA-SF分类同样显著。得分为13分的个体(与14分的个体相比)确诊的肌肉减少症(OR = 10.07, 95% CI: 1.92-52.71, P = 006)和严重的肌肉减少症(OR = 12.09, 95% CI: 1.24-117.50, P = 0.032)的风险更高。与得分为14的受试者相比,得分为12的个体确诊肌肉减少症(OR = 30.94, 95% CI: 4.25-103.02, P < 0.001)和严重肌肉减少症(OR = 35.90, 95% CI: 4.25-303.07, P = 0.001)的风险更高。模型还显示MNA-SF < 13可以预测肌肉减少症。结论MNA-SF与营养人群中确证的和严重的肌少症有显著相关性。对MNA-SF < 13患者进行肌肉减少症评估是有益的。可以考虑开发一种基于MNA-SF同时识别营养不良和肌肉减少症风险的工具。
Mini Nutrition Assessment-Short Form score is associated with sarcopenia even among nourished people – A result of a feasibility study of a registry
Objectives
This study aims to identify a new barrier to the use of the Mini-Nutrition Assessment Short-Form (MNA-SF), which is a malnutrition assessment tool for the risk assessment of sarcopenia in a nourished population.
Methods
The MNA-SF was completed, and individuals with a score of > 11 were considered nourished in this cross-sectional feasibility study of a registry. Sarcopenia was assessed in 766 healthy, nourished adults (33.4% men, 64.9 ± 7.1 years) based on the European Working Group on Sarcopenia in Older People 2 (EWGSOP2).
Results
The MNA-SF scores for non-sarcopenia, pre-, confirmed, and severe sarcopenia were 13.59 ± 0.69, 13.73 ± 0.60, 12.64 ± 0.74, and 12.5 ± 0.71, respectively. The higher MNA-SF score association with pre-sarcopenia [odds ratio (OR): 1.41, 95% confidence interval (CI): 1.06–1.86, P = 0.02], confirmed sarcopenia (OR = 0.25, 95% CI: 0.13–0.49, P < 0.001), and severe sarcopenia (OR = 0.20, 95% CI: 0.09–0.46, P < 0.001) was as significant as in the MNA-SF categories. Individuals with a score = 13 (compared with 14), had a higher risk of confirmed sarcopenia (OR = 10.07, 95% CI: 1.92–52.71, P = 006) and severe sarcopenia (OR = 12.09, 95% CI: 1.24–117.50, P = 0.032). Individuals with a score of 12 had a higher risk of confirmed sarcopenia (OR = 30.94, 95% CI: 4.25–103.02, P < 0.001) and severe sarcopenia (OR = 35.90, 95% CI: 4.25–303.07, P = 0.001) compared with subjects with a score of 14. The models also showed that MNA-SF < 13 could predict sarcopenia.
Conclusion
There was a significant association between MNA-SF and confirmed and severe sarcopenia in nourished people. Sarcopenia assessment in people with MNA-SF < 13 can be beneficial. Developing a tool to identify the risk of malnutrition and sarcopenia at the same time based on MNA-SF can be considered.